Morphine Sulfate
- Product NDC
- 76045-238
- 11-digit product format
- 760450238
- Labeler code
- 76045
- Product ID
- 76045-238_e61f6eb4-cc71-47d3-b2f6-5e689c773779
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Morphine Sulfate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi, USA LLC
- Application
- NDA204223
- Marketing category
- NDA
- Marketing start
- 2013-10-30
- Substance
- MORPHINE SULFATE
- Active strength
- 1 mg/.5mL
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204223-001 | MORPHINE SULFATE | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | |
| N204223-002 | MORPHINE SULFATE | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | |
| N204223-003 | MORPHINE SULFATE | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | |
| N204223-004 | MORPHINE SULFATE | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | |
| N204223-005 | MORPHINE SULFATE | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Morphine Sulfate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MORPHINE SULFATE | 1 mg/.5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| X3P646A2J0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1f53de80-efc8-4930-b3e3-fba0d026af05 | Available on FDA.report |
DailyMed Product Concepts#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi, USA LLC | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 204223 NDA204223 76045-238 |
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi USA, LLC | 582f42e5-444e-4246-af8c-e7e28097c69a | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | 204223 NDA204223 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 894912 | morphine sulfate 10 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | morphine sulfate 2 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | morphine sulfate 4 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | morphine sulfate 5 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | morphine sulfate 8 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894912 | 1 ML morphine sulfate 10 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | 1 ML morphine sulfate 2 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | 1 ML morphine sulfate 4 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | 1 ML morphine sulfate 5 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | 1 ML morphine sulfate 8 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894912 | 1 ML MS 10 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | 1 ML MS 2 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | 1 ML MS 4 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | 1 ML MS 5 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | 1 ML MS 8 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894912 | morphine sulfate 10 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | morphine sulfate 2 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | morphine sulfate 4 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | morphine sulfate 5 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | morphine sulfate 8 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 76045-238-10 | 76045023810 | 10 SYRINGE, GLASS in 1 CARTON (76045-238-10) / .5 mL in 1 SYRINGE, GLASS (76045-238-01) | 2026-05-29 | No | No | Current |